中文

REGENERON PHARMACEUTICALS, INC. Revenue Breakdown

Period 2026-03-31 (quarterly) ・ Reported 2026-04-29
ItemAmountY/Y
Revenue$3.61B+19.0%
Gross profit$3.61B
Operating income$0.64B
Net income$0.73B-10.1%
Gross margin100.0%Net margin 20.2%

Revenue Segments

SegmentRevenueShare
Collaboration Revenue$1.90B52.7%
Product$1.53B42.6%
LIBTAYONet Product Sales$0.44B12.2%
Product And Service Other$0.17B4.7%
Other Products$0.03B0.9%
Lynozyfic$0.01B0.3%

Costs & Expenses

ItemAmount% of revenue
R&D$1.54B42.8%
SG&A$0.65B18.0%
Tax & other$-0.08B-2.3%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

RFRSGRMDRVTYHOODROKROLROPROSTRCLSPGICRM

Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies